Latest Capital Raising News

European Lithium Limited has launched a replacement options offer for holders of 205 million expiring options, with directors committing to fully participate and underwrite the offer pending shareholder approval at the upcoming AGM.

BCAL Diagnostics has launched a $10 million convertible note facility, with $5 million already committed, to strengthen its capital position and accelerate commercialisation of its cancer detection technologies.

Scout Security has raised a further $220,000 through a share placement, bringing total capital raised to $820,000, as it works toward resolving its trading suspension.

Diablo Resources will join a high-profile lunch in Washington, D.C., with Australian Prime Minister Anthony Albanese and Ambassador Kevin Rudd, spotlighting its role in the evolving US-Australia critical minerals partnership.

Australian Strategic Materials secures A$50.8 million via share placement to fund Korean plant expansion and advance US metals project, while navigating complex supply chain and funding risks.

ASM Limited has raised A$55 million to accelerate production capacity at its Korean Metals Plant and expand its footprint in the rare earths sector, responding to growing global demand and geopolitical supply chain pressures.

Asian Battery Metals PLC has successfully raised $6 million through an oversubscribed equity placement, positioning the company to advance exploration and acquisition efforts across its Mongolian battery metals projects.

AdAlta Limited has raised up to A$1.1 million through a private placement, boosting its war chest to advance innovative cellular immunotherapy projects targeting solid cancers.

Horizon Gold advances its Gum Creek project with significant gold intercepts from water bore drilling and launches an AI-powered exploration platform, while maintaining its feasibility study timeline and securing $12 million in fresh capital.

Metal Powder Works Limited (MPW) has landed a $1 million contract with the US Navy for its innovative expeditionary DirectPowder™ unit, while expanding its alloy portfolio and customer base amid a $15 million capital raise.

Radiopharm Theranostics has completed a A$35 million institutional placement and launched a A$5 million Share Purchase Plan, both at $0.03 per share, to fund drug manufacturing and clinical trials through 2027.

Prospech Limited reports steady progress on rare earth element metallurgy at its Korsnäs project and promising gold-silver drill results in Slovakia, backed by a fully subscribed $2.1 million capital raising.